As populations around the world age, the intersection of aging and substance use disorders (SUDs) has emerged as one of the most pressing yet underaddressed public health challenges of our time. Traditional drug policies, designed primarily with younger populations in mind, often fail to account for the unique physiological, psychological, and social needs of older adults struggling with addiction. This gap in policy and practice has created significant barriers to treatment, leaving millions of older adults without adequate support. Addressing these challenges requires a comprehensive reevaluation of current drug policy strategies to create more inclusive, age-appropriate, and effective interventions that recognize the distinct needs of aging populations.
Understanding the Scope: The Growing Demographic of Older Adults with Substance Use Disorders
Nearly 1 million adults aged 65 and older live with a substance use disorder, and this number continues to rise at an alarming rate. The number of adults aged 55 and over who sought out addiction treatments increased by more than 50 percent between 2009 and 2020, reflecting a dramatic shift in the demographic landscape of substance use.
Between 2022 and 2023, the drug related death rate increased by 2.3% for adults aged 55-64 and by 11.4% for adults 65 and older. These statistics paint a sobering picture of a crisis that is intensifying rather than diminishing. Overdose deaths are dropping for younger people, but older adults (65 and up) saw only a small decline of 8.8%, highlighting the disproportionate impact on this vulnerable population.
The Baby Boomer Effect and Changing Patterns of Substance Use
This increase is believed to be partially endorsed by the baby boomer generation, born between 1946 to 1964, who had significant exposure to alcohol and drugs at a younger age. The baby boomer generation has had higher rates of substance use at each stage of life compared to previous generations, due to shifting attitudes toward substance use during their upbringing and increased life expectancy.
The substances most commonly misused by older adults differ somewhat from those used by younger populations. The most common substances abused are alcohol, prescription drugs such as opiates and benzodiazepines (BZD), and over-the-counter (OTC) medications. About 65% of people 65 and older report high-risk drinking, defined as exceeding daily guidelines at least weekly in the past year, and more than a tenth of adults age 65 and older currently binge drink.
Prescription drug misuse represents a particularly concerning trend among older adults. Chronic health conditions tend to develop as part of aging, and older adults are often prescribed more medicines than other age groups, leading to a higher rate of exposure to potentially addictive medications. One study of 3,000 adults aged 57-85 showed common mixing of prescription medicines, nonprescription drugs, and dietary supplements, with more than 80% of participants using at least one prescription medication daily, and nearly half using more than five medications or supplements.
Contributing Factors to Substance Use in Older Adults
Multiple interconnected factors contribute to the rising rates of substance use disorders among older adults. Physical risk factors for substance use disorders in older adults can include chronic pain, physical disabilities or reduced mobility, transitions in living or care situations, loss of loved ones, forced retirement or change in income, poor health status, chronic illness, and taking a lot of medicines and supplements.
One of the primary reasons older people struggle with substance use disorders is a decrease in family support and social interaction as they age. Social isolation is common among older adults as family members and friends move away or pass away. When seniors lack meaningful relationships or become socially isolated, it can lead to feelings of loneliness, which increases their risk for developing mental health issues like depression—all of which can contribute to higher rates of substance abuse.
The COVID-19 pandemic exacerbated many of these risk factors. This alarming trend is due to a combination of factors—including an increase in access to prescription drugs and alcohol and a decrease in family support and social interaction that occurred during the pandemic.
Unique Physiological and Health Considerations in Older Adults
The aging process fundamentally changes how the body processes and responds to substances, making older adults particularly vulnerable to the harmful effects of drugs and alcohol. Older adults typically metabolize substances more slowly, and their brains can be more sensitive to drugs. These physiological changes mean that substances that might have been tolerable at younger ages can become dangerous or even lethal in older adulthood.
Increased Medical Complications and Comorbidities
Older adults may be more likely to experience mood disorders, lung and heart problems, or memory issues. Drugs can worsen these conditions, exacerbating the negative health consequences of substance use. A key consideration in the treatment of older adults with SUD is that they often have co-occurring general medical illnesses. Substance use can complicate the course and management of existing illnesses and they, in turn, can worsen the consequences of substance use and SUD.
The use of alcohol and benzodiazepines has been associated with an increased risk of falls, cognitive impairment, and delirium in older adults. Stimulants can be particularly lethal to older adults due to the high rates of cardiovascular disease in this population. The effects of some drugs—like impaired judgment, coordination, or reaction time—can result in accidents, such as falls and motor vehicle crashes. These sorts of injuries can pose a greater risk to health than in younger adults and coincide with a possible longer recovery time.
Substance use disorder in older people can also worsen, or precipitate an earlier onset of, conditions such as cognitive impairment and frailty. This creates a vicious cycle where substance use accelerates age-related decline, which in turn may increase reliance on substances to cope with deteriorating health and function.
Mortality and Overdose Risks
The mortality consequences of substance use in older adults are severe and worsening. According to the CDC, alcohol was an underlying cause of death for 11,616 adults aged 65 and over in 2020. Although alcohol caused very few deaths in this age group, the rates have increased in recent years. In fact, the number of older adults dying from alcohol-related causes rose by 18.2 percent between 2019 and 2020.
Drug overdoses and deaths caused by overdose, including among older adults, are occurring at record-high rates in the USA, where deaths from overdose in older adults have tripled between 2002 and 2021. 57% of drug deaths among 65-plus users involved opioids and 39% involved stimulants, demonstrating the polysubstance nature of the crisis affecting older adults.
Critical Challenges in Current Drug Policies and Treatment Systems
Despite the growing prevalence of substance use disorders among older adults, current drug policies and treatment systems remain inadequately equipped to address their needs. Multiple systemic barriers prevent older adults from accessing appropriate care and achieving successful recovery outcomes.
Severe Shortage of Age-Appropriate Treatment Programs
Only 18% of substance abuse treatment programs are designed for this growing population. This statistic reveals a fundamental mismatch between the growing need for geriatric-focused addiction treatment and the available resources. Despite the increasing prevalence and high risk of substance-related harms in older people, less than a third of substance use disorder treatment programmes are tailored for this population group.
While only 18% of substance abuse treatment programs were specifically designed for the geriatric population, the general availability of SUD treatment facilities is limited for those of lower socioeconomic status, making it even more difficult for these patients to seek proper care for their SUDs. This creates compounding disadvantages for older adults who face both age-related barriers and socioeconomic challenges.
The current treatment model for substance use disorders in the United States is neither age-friendly nor designed to care for a population with multimorbidity and functional impairments. Treatment programs designed for younger adults often fail to address the complex medical, cognitive, and social needs that characterize older adults with substance use disorders.
Inadequate Healthcare Provider Training and Screening
Despite increasing rates of substance use in older adults, the number of referrals made by healthcare providers for substance use treatment has been declining. This troubling trend suggests that healthcare providers are either failing to recognize substance use disorders in their older patients or are not equipped to make appropriate referrals.
SUD can be difficult to recognize in older adults and lead to treatment delays due to medical comorbidity, neurocognitive impairment, and functional decline. It is challenging to recognize substance abuse in older adults. It is frequently under-diagnosed, because it can be present as dementia, anxiety, and/or depression.
Despite this, older adults are often not screened or offered evidence-based treatment for substance use disorder. The lack of routine screening in primary care and geriatric settings means that many cases go undetected until they reach crisis levels, missing critical opportunities for early intervention.
Persistent Stigma and Ageism
Stigma surrounding substance use in older populations creates significant barriers to treatment seeking and provision. Older adults with SUD may have experienced stigma over their life course and as part of their treatment experiences, and the combination of aging and drug use may exacerbate social isolation.
Current treatment systems, influenced by structural ageism and racism, limit the ability of older adults to access evidence-based treatment that is age-friendly. This structural ageism manifests in multiple ways, from the design of treatment programs that assume physical mobility and cognitive abilities typical of younger adults, to implicit biases among healthcare providers who may view substance use treatment as less worthwhile for older patients.
Racial and Socioeconomic Disparities
There are stark racial and ethnic disparities seen among older adults. They reflect unequal access to buprenorphine for opioid use disorder and fewer investments in providing addiction treatment and harm-reduction interventions for minority populations, the homeless, and justice-involved persons.
Age trends in SUDs across ages 18–90 showed that disparities by race/ethnicity varied with age; for example, SUDs were more prevalent in Black adults at older ages and more prevalent in White adults at younger ages. Among older adults, Black older adults were 37% less likely to complete a substance use treatment program than Whites, while Hispanic older adults were 26% more likely to complete a substance use treatment than Whites.
Low Treatment Utilization Rates
Belonging to an older cohort decreased the probability of ever receiving treatment for a substance use disorder. Among adults ages 65 and older with SUD, in 2018, 24 percent received treatment for drug use disorders, and 16.8 percent received treatment for alcohol use disorders. These low treatment rates represent a massive gap between need and service delivery.
Individuals ages 65 and older have lower odds of perceived treatment need than younger individuals, and often report a lack of readiness to stop using substances as one of their primary reasons to not seek treatment. As a result, older adults are more likely to be referred to SUD treatment from other sources such as community social service providers than from healthcare providers.
Evidence-Based Policy Strategies for Age-Inclusive Drug Policy
Creating effective drug policies for aging populations requires a multifaceted approach that addresses the unique needs of older adults while integrating with existing healthcare and social support systems. The following strategies represent evidence-based approaches to improving outcomes for older adults with substance use disorders.
Developing Age-Specific Treatment Programs and Guidelines
The Substance Abuse and Mental Health Services Administration (SAMHSA)'s 2020 Treatment Improvement Protocol (TIP 26) is a set of guidelines describing evidence-based practices for treating SUDs in older adults. Treatment Improvement Protocol 26 includes recommendations for specialized services such as providing screening and support for cognitive impairment, case management focused on connections to age-related community resources and/or geriatrics specialists, and age-matched peer recovery support.
STM approaches arose out of a concern about whether older adults could effectively engage in standard treatment. It was observed that confrontational approaches were ill suited and disrespectful to older adults and that the unique issues faced by older individuals, including health conditions, depression comorbidity, and social isolation, went unaddressed. STM were designed to focus on developing a culture of support and successful coping for older-adult substance abusers; supportive therapies concentrate on building social support, improving self-esteem, and taking a global approach to treatment planning through addressing multiple biopsychosocial arenas in the client's life.
Age-specific treatment programs should incorporate slower pacing, address sensory impairments, provide transportation assistance, and create peer groups with age-matched participants. These modifications recognize the distinct developmental stage and life circumstances of older adults, creating an environment where they feel understood and supported rather than marginalized.
Integrating Geriatric Care Principles with Addiction Treatment
Incorporating geriatric care principles—such as the 4Ms framework (Matters Most, Medication, Mentation, and Mobility)—into addiction treatment programs can better address the complex needs of older adults. This framework ensures that treatment addresses not only substance use but also the broader health and functional needs of older adults.
For this population, the goal should be integrated and coordinated geriatric-based care that focuses on maintaining function and managing chronic conditions, including geriatric conditions, in coordination with substance use disorder treatment. To improve the health of this vulnerable population, approaches to care tailored to older people must be developed and integrated with addiction treatment to build age-friendly health systems that can address substance use disorder among older adults.
Integration should occur at multiple levels, including co-location of services, shared electronic health records, care coordination teams, and cross-training of staff. Geriatricians should be equipped to provide addiction treatment, and addiction specialists should be trained in geriatric care principles.
Expanding Access to Medication-Assisted Treatment
Geriatricians and other geriatric care clinicians should prescribe evidence-based medications such as buprenorphine for opioid use disorder or naltrexone for alcohol use disorder. Continuing such medications is especially critical during transitions of care that many patients with multiple chronic diseases experience.
Just as clinicians would not withhold insulin for patients with diabetes who are discharged from the hospital to a skilled nursing facility or to home-based care, withholding medications for substance use disorder should not be tolerated, either. This principle establishes medication-assisted treatment as a standard of care rather than an optional intervention.
Policy makers and regulators must make clear that all older adults living with substance use disorder must have access to lifesaving, evidence-based treatment in all settings where they receive clinical care. This includes nursing homes, assisted living facilities, home health care, and hospital settings—all places where older adults commonly receive care but where addiction treatment has historically been unavailable or prohibited.
Implementing Comprehensive Screening and Early Intervention
Routine screening for substance use in older adults is essential to identify misuse early, as symptoms often overlap with typical aging or medical problems. Healthcare providers should incorporate validated screening tools such as AUDIT-C and CAGE for alcohol, CARET and MAST-G tailored to older adults, and ASSIST or CAGE-AID for drug use detection.
Using nonconfrontational approaches like motivational interviewing helps address substance use sensitively, encourages openness, and respects cultural backgrounds. Culturally sensitive assessments improve detection and connection to care, especially important due to racial and socioeconomic disparities affecting this population.
Screening should be integrated into routine primary care visits, geriatric assessments, hospital admissions, and transitions of care. Electronic health record systems should include prompts for substance use screening at appropriate intervals, and positive screens should trigger automatic referrals to appropriate treatment resources.
Enhancing Healthcare Provider Education and Training
Medical schools, nursing programs, social work education, and continuing education for practicing clinicians must incorporate comprehensive training on substance use disorders in older adults. This training should cover the unique presentation of SUDs in older adults, age-appropriate screening tools, evidence-based treatment approaches, and strategies for addressing stigma and ageism.
Geriatric fellowship programs should include addiction medicine as a core competency, and addiction medicine fellowship programs should include geriatric principles. Cross-training initiatives can help break down silos between these specialties and create a workforce equipped to address the complex needs of older adults with substance use disorders.
Training should also address implicit biases and ageist attitudes that may prevent healthcare providers from recognizing substance use disorders in older patients or offering appropriate treatment. Healthcare providers need to understand that recovery is possible at any age and that older adults deserve the same access to evidence-based treatment as younger populations.
Addressing Social Determinants of Health
Better integration of SUD and general medical treatment, and increased attention to social determinants of health, are important future directions for research and treatment of SUD in elders. Social isolation, housing instability, food insecurity, transportation barriers, and lack of social support all contribute to substance use and impede recovery.
Drug policies should support interventions that address these social determinants, including funding for senior centers that provide social connection, transportation services to treatment appointments, housing programs that accommodate older adults in recovery, and peer support programs that connect older adults with others who have experienced similar challenges.
Community-based programs can play a vital role in prevention and early intervention. Senior centers, faith communities, meal delivery programs, and other services that regularly interact with older adults should receive training on recognizing signs of substance use and making appropriate referrals.
Reducing Stigma Through Public Awareness Campaigns
Public awareness campaigns specifically targeting substance use in older adults can help reduce stigma, increase help-seeking behavior, and educate families and communities about available resources. These campaigns should challenge stereotypes about aging and addiction, highlight recovery success stories from older adults, and provide information about how to access treatment.
Campaigns should be disseminated through channels that reach older adults and their families, including television, radio, print media, senior centers, healthcare facilities, and community organizations. Messages should be age-appropriate, culturally sensitive, and emphasize hope and the possibility of recovery at any age.
Expanding Research on Substance Use in Older Adults
Little is known about the effects of drugs and alcohol on the aging brain. Knowledge of substance use disorders (SUD) in adults ages 65 and older is limited. Yet knowledge of substance use and substance use disorders (SUD) in this cohort lags behind knowledge about the same issues in younger age groups.
Research funding should prioritize studies examining the effectiveness of different treatment approaches for older adults, the optimal dosing and safety of medications for substance use disorders in older populations, the interaction between substance use and age-related conditions, and strategies for preventing substance use disorders in older adults.
Clinical trials for new addiction treatments should include adequate representation of older adults to ensure that safety and efficacy data are available for this population. Current exclusion of older adults from many clinical trials creates knowledge gaps that leave clinicians without evidence-based guidance for treating their older patients.
Policy Recommendations for Healthcare Systems and Payers
Medicare and Insurance Coverage Reforms
Medicare covers certain mental health and substance use disorder services. For example, Medicare Part B takes care of costs for services in opioid treatment programs. However, coverage gaps remain that create barriers to comprehensive treatment.
Policy reforms should ensure that Medicare and other insurance programs covering older adults provide comprehensive coverage for all evidence-based addiction treatments, including residential treatment, intensive outpatient programs, medication-assisted treatment, counseling, case management, and recovery support services. Coverage should extend to age-appropriate modifications such as transportation assistance, home-based treatment options, and extended treatment durations that may be necessary for older adults with complex medical needs.
Reimbursement rates should be adequate to support the development and sustainability of specialized geriatric addiction treatment programs. Current reimbursement structures often fail to account for the additional time and resources required to treat older adults with multiple comorbidities and complex psychosocial needs.
Regulatory Reforms for Treatment Facilities
Regulations governing substance use disorder treatment facilities should include standards for age-friendly care, including physical accessibility, accommodation of sensory and cognitive impairments, integration with medical care, and staff training in geriatric principles. Licensing and accreditation processes should evaluate facilities on their capacity to serve older adults effectively.
Nursing homes, assisted living facilities, and other long-term care settings should be required to provide or facilitate access to addiction treatment for residents with substance use disorders. Current regulations often create barriers to providing addiction treatment in these settings, leaving residents without access to necessary care.
Workforce Development Initiatives
Federal and state governments should invest in workforce development programs that train healthcare providers, social workers, and peer support specialists in geriatric addiction treatment. Loan forgiveness programs, scholarships, and other incentives can encourage professionals to specialize in this underserved area.
Peer support specialists who are older adults in recovery can provide invaluable support and serve as role models for others. Training and certification programs for peer support specialists should include pathways specifically designed for older adults, and employment of older peer support specialists should be encouraged through funding mechanisms and program requirements.
Harm Reduction Strategies Tailored to Older Adults
Harm reduction approaches recognize that not all individuals are ready or able to achieve abstinence and focus on reducing the negative consequences of substance use. These strategies are particularly important for older adults who may have used substances for decades and face significant barriers to traditional abstinence-based treatment.
Supervised Consumption Sites and Overdose Prevention
Supervised consumption sites, where individuals can use drugs under medical supervision with access to sterile equipment and overdose reversal medications, have demonstrated effectiveness in reducing overdose deaths and connecting people to treatment services. These facilities should be designed to accommodate the needs of older adults, including physical accessibility and integration with geriatric healthcare services.
Naloxone distribution programs should specifically target older adults and their caregivers, with training adapted to address the unique overdose risks faced by older adults. Given the high rates of prescription opioid use among older adults, naloxone should be routinely co-prescribed when opioids are prescribed to older patients.
Safer Prescribing Practices
Prescription drug monitoring programs should include age-specific alerts that flag potentially dangerous prescribing patterns in older adults, such as concurrent prescriptions for opioids and benzodiazepines, high-dose opioid prescriptions, or prescriptions from multiple providers.
Clinical guidelines for prescribing potentially addictive medications to older adults should emphasize starting with the lowest effective dose, regular reassessment of continued need, tapering strategies when discontinuation is appropriate, and integration with non-pharmacological pain management and mental health treatment approaches.
Housing and Social Support
Housing programs should accommodate older adults in recovery, recognizing that traditional recovery housing may not be appropriate for individuals with mobility limitations, chronic health conditions, or other age-related needs. Supportive housing models that integrate addiction treatment with geriatric care and social services can provide a stable foundation for recovery.
Social support interventions should address the isolation that contributes to substance use among older adults. Programs that facilitate social connection, meaningful activities, and community engagement can both prevent substance use and support recovery.
International Perspectives and Best Practices
Countries around the world are grappling with similar challenges related to aging populations and substance use disorders. Examining international approaches can provide valuable insights for policy development.
Some European countries have developed comprehensive age-friendly addiction treatment systems that integrate substance use disorder treatment with geriatric care, provide extensive social support services, and emphasize harm reduction approaches. These models demonstrate the feasibility of creating systems that effectively serve older adults with substance use disorders.
International collaboration on research, policy development, and sharing of best practices can accelerate progress in addressing this global challenge. Organizations such as the World Health Organization can play a role in developing international guidelines and facilitating knowledge exchange.
The Role of Technology in Expanding Access
Telehealth and digital health technologies offer promising opportunities to expand access to addiction treatment for older adults, particularly those in rural areas, those with mobility limitations, or those who face transportation barriers.
However, satisfaction with telehealth among older adults showed lower satisfaction among those with lower socioeconomic status and among certain minorities including Black, Hispanic, and Native Americans. This highlights the importance of addressing digital divides and ensuring that technology-based interventions are accessible and acceptable to diverse populations of older adults.
Telehealth programs for older adults should include technical support, accommodate sensory and cognitive impairments, and be integrated with in-person services when needed. Hybrid models that combine telehealth with periodic in-person visits may be optimal for many older adults.
Digital therapeutics, mobile applications, and online support groups can supplement traditional treatment approaches, but should be designed with the needs and preferences of older adults in mind, including larger text, simplified interfaces, and content that is relevant to their life stage and experiences.
Family and Caregiver Involvement
Family members and caregivers play crucial roles in recognizing substance use problems, supporting treatment engagement, and providing ongoing support for recovery. Drug policies and treatment programs should actively involve families and caregivers while respecting the autonomy and privacy of older adults.
Education programs for families and caregivers should provide information about substance use disorders in older adults, how to recognize warning signs, how to approach conversations about substance use, and how to access treatment and support services. These programs should address the complex emotions that family members may experience, including guilt, shame, anger, and grief.
Support groups specifically for families and caregivers of older adults with substance use disorders can provide peer support, practical advice, and emotional validation. These groups should be widely available and promoted as a standard component of comprehensive care.
Policies should also address the needs of older adults who are themselves caregivers, as caregiver stress is a risk factor for substance use. Respite care, caregiver support services, and recognition of the intersection between caregiving and substance use can help prevent and address substance use disorders in this population.
Legal and Ethical Considerations
Drug policies affecting older adults must navigate complex legal and ethical terrain, balancing individual autonomy, public health, and the duty to protect vulnerable populations.
Capacity and Consent
Older adults with substance use disorders may have impaired decision-making capacity due to cognitive decline, substance-induced impairment, or co-occurring mental health conditions. Policies should provide clear guidance on assessing capacity, obtaining informed consent for treatment, and involving surrogate decision-makers when necessary, while maximizing the autonomy and self-determination of older adults.
Mandatory Reporting and Intervention
Adult protective services laws in many jurisdictions require reporting of vulnerable adults who are unable to care for themselves. Policies should clarify when substance use in older adults triggers mandatory reporting obligations and ensure that interventions prioritize treatment and support rather than punitive approaches.
Criminal Justice Considerations
Older adults with substance use disorders may become involved in the criminal justice system through drug possession charges, driving under the influence, or other offenses related to their substance use. Drug courts, diversion programs, and alternative sentencing options should be available and appropriate for older adults, with connections to age-appropriate treatment and support services.
Incarcerated older adults with substance use disorders face particular challenges, as correctional facilities are often ill-equipped to provide geriatric care or addiction treatment. Policies should ensure access to medication-assisted treatment, mental health services, and discharge planning that connects older adults to community-based treatment and support upon release.
Economic Considerations and Cost-Effectiveness
Investing in comprehensive addiction treatment for older adults is not only a moral imperative but also makes economic sense. Untreated substance use disorders in older adults generate substantial costs through emergency department visits, hospitalizations, nursing home placements, and other healthcare utilization.
Studies have demonstrated that addiction treatment is cost-effective, with savings from reduced healthcare utilization, decreased criminal justice involvement, and improved quality of life outweighing the costs of treatment. For older adults, the potential for reducing expensive medical complications and preventing premature nursing home placement makes treatment particularly cost-effective.
Economic analyses should consider the full range of costs and benefits, including impacts on family caregivers, quality of life, and the ability of older adults to remain independent and engaged in their communities. Policies should be informed by comprehensive cost-effectiveness analyses that account for the unique characteristics of older adults with substance use disorders.
Prevention Strategies for Future Cohorts
While addressing the current crisis of substance use disorders among older adults is urgent, prevention strategies targeting middle-aged and younger adults can reduce the burden of substance use disorders in future cohorts of older adults.
Prevention efforts should address the risk factors that contribute to substance use in later life, including chronic pain, mental health conditions, social isolation, and transitions such as retirement and bereavement. Promoting healthy aging, maintaining social connections, developing effective coping strategies, and addressing mental health needs can all reduce the risk of developing substance use disorders in later life.
Public health campaigns should challenge ageist stereotypes that portray substance use as exclusively a problem of youth and educate people of all ages about the risks of substance use in later life. Normalizing conversations about substance use across the lifespan can reduce stigma and encourage early help-seeking.
Healthcare providers should engage in anticipatory guidance with middle-aged and younger patients about the risks of substance use as they age, particularly in the context of chronic pain management, mental health treatment, and life transitions. Proactive conversations about safer use of alcohol and medications can prevent the development of substance use disorders.
Building a Comprehensive Policy Framework
Effective drug policy for aging populations requires a comprehensive framework that integrates multiple levels of intervention, from individual clinical care to population-level public health strategies. This framework should be guided by several core principles:
Person-centered care: Policies and programs should be designed around the needs, preferences, and goals of older adults, recognizing their autonomy and dignity while providing appropriate support and protection.
Integration: Substance use disorder treatment should be integrated with geriatric care, primary care, mental health services, and social support services, creating seamless systems of care rather than fragmented silos.
Evidence-based practice: Policies should be informed by research evidence on what works for older adults with substance use disorders, with ongoing evaluation and quality improvement to ensure effectiveness.
Equity: Policies must address the disparities in access and outcomes experienced by older adults from racial and ethnic minority groups, those with lower socioeconomic status, and other marginalized populations.
Harm reduction: Policies should embrace harm reduction approaches that meet people where they are, reduce the negative consequences of substance use, and create pathways to recovery that may not require immediate abstinence.
Life course perspective: Policies should recognize that substance use disorders in older adults often have roots in earlier life experiences and that prevention and early intervention across the lifespan can reduce the burden of substance use disorders in later life.
Implementation Challenges and Strategies for Success
Implementing comprehensive drug policies for aging populations faces numerous challenges, including limited resources, workforce shortages, fragmented systems of care, and resistance to change. Successful implementation requires strategic approaches that address these challenges.
Stakeholder engagement is essential, bringing together older adults with lived experience, family members, healthcare providers, policymakers, researchers, and community organizations to collaboratively design and implement policies. Meaningful involvement of older adults themselves ensures that policies are responsive to their needs and preferences.
Pilot programs and demonstration projects can test innovative approaches, generate evidence of effectiveness, and build support for broader implementation. Lessons learned from early adopters can inform refinement and scaling of successful interventions.
Sustainable funding mechanisms are necessary to support the development and maintenance of age-appropriate addiction treatment programs. This may include dedicated funding streams, reimbursement reforms, and creative financing approaches that leverage multiple funding sources.
Quality metrics and accountability mechanisms ensure that programs are delivering effective, age-appropriate care. Performance measurement should include both process measures (such as screening rates and access to medication-assisted treatment) and outcome measures (such as treatment retention, quality of life, and functional status).
The Path Forward: A Call to Action
The intersection of aging populations and substance use disorders represents one of the defining public health challenges of the coming decades. It is estimated that the number of geriatric persons, adults aged 65 or older, in the United States will be approximately 72.1 million by 2030. Without significant policy reforms and system changes, millions of older adults will continue to suffer from untreated substance use disorders, experiencing preventable morbidity, mortality, and diminished quality of life.
The evidence is clear that effective interventions exist, that treatment works for older adults, and that comprehensive, age-appropriate approaches can dramatically improve outcomes. What is lacking is not knowledge but rather the political will, resource allocation, and system transformation necessary to translate evidence into practice at scale.
Policymakers at all levels of government must prioritize this issue, allocating resources, reforming regulations, and creating accountability for serving older adults with substance use disorders. Healthcare systems must transform their approaches, integrating addiction treatment with geriatric care and ensuring that all older adults have access to evidence-based treatment.
Healthcare providers must overcome ageist attitudes and knowledge gaps, recognizing substance use disorders in their older patients and providing or facilitating access to appropriate treatment. Families and communities must challenge stigma, support older adults in recovery, and advocate for policies and programs that meet their needs.
Researchers must continue to generate evidence on effective approaches, filling knowledge gaps and evaluating innovative interventions. Older adults themselves must be empowered to seek help, participate in treatment, and share their experiences to inform policy and reduce stigma.
Conclusion: Creating Age-Friendly Drug Policies for Healthier Aging
As the demographic landscape continues to shift toward an increasingly older population, the imperative to adapt drug policies to meet the needs of aging populations has never been more urgent. The current crisis of substance use disorders among older adults demands immediate action, but it also presents an opportunity to fundamentally reimagine how we approach addiction across the lifespan.
Creating age-friendly drug policies requires moving beyond one-size-fits-all approaches to recognize the unique needs, strengths, and challenges of older adults. It requires integrating addiction treatment with geriatric care, addressing social determinants of health, reducing stigma and ageism, and ensuring equitable access to evidence-based treatment for all older adults regardless of race, ethnicity, socioeconomic status, or geographic location.
The strategies outlined in this article—from developing age-specific treatment programs and enhancing provider training to implementing harm reduction approaches and addressing social isolation—provide a roadmap for policy reform. Implementation will require sustained commitment, adequate resources, and collaboration across sectors and disciplines.
The stakes could not be higher. Every day that passes without adequate policy responses represents another day of suffering for older adults with substance use disorders and their families. But with comprehensive, evidence-based, and compassionate policies, we can create systems of care that support healthy aging, facilitate recovery at any age, and honor the dignity and worth of all older adults.
By adopting inclusive, informed, and age-appropriate drug policies, we can not only address the current crisis but also build a foundation for healthier aging for future generations. This is not merely a matter of public health policy—it is a reflection of our values as a society and our commitment to ensuring that all people, regardless of age, have the opportunity to live healthy, fulfilling lives free from the devastating impacts of untreated substance use disorders.
For more information on substance use disorders and treatment options, visit the Substance Abuse and Mental Health Services Administration or the National Institute on Drug Abuse. Organizations such as the American Society on Aging provide resources specifically focused on aging and substance use, while the Centers for Disease Control and Prevention offers data and guidance on substance use across the lifespan. The National Institute on Aging provides research and educational resources on healthy aging and age-related health conditions.